He focuses on value and notes that innovation is not occurring in health care “because of the inflexibility in the payment system and misaligned incentive.” Particularly, innovation regarding the management of chronic disease which accounts for 70% of medical cost.

There will certainly be alot of discussion on realigning incentives to pay for outcomes rather than volume in the upcoming healthcare reform debates. It is long overdue.